Streptococcus salivarius K12 | CMAC

Streptococcus salivarius K12

Two-level combined probiotics – a new paradigm for the prevention of respiratory tract infections and antibiotic-associated conditions

In light of the widespread growth of antimicrobial resistance, the decline in the effectiveness of existing antibiotics, and the global shortage of innovative antibacterial drugs, preventing infectious diseases and preserving antibiotics for future …

New probiotic strain Streptococcus salivarius K12 in clinical practice

Over the last decades, probiotic strains for topical administration (including oral cavity) have appeared in clinical practice. Streptococcus salivarius K12 is a promising probiotic for prevention and treatment of the upper respiratory tract and ENT …